This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ahmed, F. Articles by Sneller, V.-P. Search for Related Content PubMed PubMed Citation Articles by Ahmed, F. Articles by Sneller, V.-P. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Managed Care Social Bookmarking                         What's this?

Cost-Benefit Analysis of a New HEDIS Performance Measure for Pneumococcal Vaccination

Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA fahmed{at}cdc.gov

Elamin E. Elbasha, PhD

Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA

Betsy L. Thompson, MD, MSPH

Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA

Jeffrey R. Harris, MD, MPH

Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA

Vishnu-Priya Sneller, MBBS, PhD

National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA

Objectives. Measurement ofthe quality of care provided by managed care organizations (MCOs) has achieved national prominence, though there is controversy regarding its value. This article assesses the economic implications ofa new Health Plan Employer Data and Information Set (HEDIS®) measure for pneumococcal vaccination. Methods.A Markov decision model, with Monte Carlo simulations, was utilized to conduct a cost-benefit analysis of annual HEDIS-associated interventions, which were repeated for 5 consecutive years, in an average Medicare MCO, using a societal perspective and a 3% annual discount rate. Results.Compared with the status quo, the HEDIS intervention will be cost saving 99.8% ofthe time, with an average net savings of $3.80 per enrollee (95% probability interval: $0.73 $6.87). Conclusions.The new HEDIS measure will save societal dollars. This type of analysis is essential if performance measurement is to become a legitimate part of our health care landscape.

Key Words: cost-benefit • cost-effectiveness • health maintenance organizations • intervention • managed care programs • outcomes assessment (health care) • performance measures • pneumococcal vaccine • quality of health care

Medical Decision Making, Vol. 22, No. 5 suppl, S58-S66 (2002)
DOI: 10.1177/027298902237711


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. K. Owens Analytic Tools for Public Health Decision Making Med Decis Making, October 1, 2002; 22(5_suppl): S3 - S10. [PDF]